FDA Approves Natalizumab For Sandoz And Polpharma Biologics

Tyruko Biosimilar Rival To Tysabri Approved In US Following Recent European Nod

 
• By David Wallace
  
US flag thumbs up
Tyruko has now been approved in the US • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin